In accordance
with 5 CFR 1320, the information collection is approved for three
years. However, should the agency changes the survey instrument as
outlined in the supplementary document "Gluten Addendum," they must
submit the final draft for OMB approval prior to conducting the
survey. They may submit their request for approval as a
"non-substantive" change.
Inventory as of this Action
Requested
Previously Approved
02/28/2013
36 Months From Approved
17,140
0
0
2,015
0
0
0
0
0
Under section 903b of the Federal food
Drug and Cosmetic Act (the act),(21 U.S.C.393 (b)(2), FDA is
authorized to conduct research relating to foods and to conduct
educational and public information programs relating to the safety
of the nations food supply. The 'Gluten - Free Labeling of Food
Products Experimental study" will collect infomationfrom both
consumers who have celiac disease or gluten intolerance and those
who do not have either condition. The purpose of the study is to
guage perceptions of characteristics related to claims of "gluten
free." Further, the results of this study will be used to help FDA
define how gluten-free terms can be used on food product
labels.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.